UBS Group Upgrades Astera Labs (NASDAQ:ALAB) to Hold

Astera Labs (NASDAQ:ALAB) was upgraded by stock analysts at UBS Group to a “hold” rating in a report issued on Tuesday,Zacks.com reports.

Other analysts also recently issued research reports about the stock. Royal Bank Of Canada reissued an “outperform” rating and set a $250.00 target price on shares of Astera Labs in a research report on Tuesday. Weiss Ratings downgraded shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. Loop Capital initiated coverage on shares of Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 target price for the company. Citigroup initiated coverage on shares of Astera Labs in a research report on Thursday, April 2nd. They set a “buy” rating and a $200.00 target price for the company. Finally, Barclays set a $165.00 target price on shares of Astera Labs in a research report on Thursday, January 15th. Fifteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average price target of $199.74.

Astera Labs Stock Performance

ALAB opened at $191.97 on Tuesday. The firm has a 50 day moving average price of $129.78 and a 200 day moving average price of $153.49. The company has a market cap of $32.87 billion, a PE ratio of 157.35, a price-to-earnings-growth ratio of 3.46 and a beta of 1.78. Astera Labs has a 1 year low of $54.54 and a 1 year high of $262.90.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. The firm had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The company’s revenue was up 91.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, sell-side analysts predict that Astera Labs will post 1.48 earnings per share for the current year.

Insider Transactions at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.77, for a total value of $1,077,700.00. Following the completion of the transaction, the general counsel owned 118,084 shares in the company, valued at $12,725,912.68. This represents a 7.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Truett Tate sold 12,001 shares of the company’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $1,485,843.81. Following the completion of the transaction, the chief financial officer owned 192,083 shares of the company’s stock, valued at approximately $23,781,796.23. This represents a 5.88% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 1,064,888 shares of company stock worth $150,764,723 over the last 90 days. 12.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Astera Labs

A number of institutional investors and hedge funds have recently bought and sold shares of ALAB. Lido Advisors LLC increased its holdings in Astera Labs by 0.5% during the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock worth $2,046,000 after purchasing an additional 57 shares during the last quarter. Perigon Wealth Management LLC boosted its stake in shares of Astera Labs by 6.2% during the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock valued at $208,000 after buying an additional 73 shares during the last quarter. Clearstead Advisors LLC grew its position in shares of Astera Labs by 13.6% during the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after buying an additional 76 shares in the last quarter. Sound Income Strategies LLC grew its position in shares of Astera Labs by 9.2% during the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after buying an additional 76 shares in the last quarter. Finally, Venturi Wealth Management LLC increased its stake in shares of Astera Labs by 2.6% in the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock worth $546,000 after buying an additional 84 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Large customer/industry catalyst: Coverage links Astera to the Amazon‑Anthropic $100B cloud/AI commitment, which raises the prospect of multi‑year follow‑on orders for Astera’s CXL/PCIe retimers from hyperscalers. This is being read as a tangible demand driver for future revenue. Anthropic Amazon Deal Benefits Marvell & Astera
• Positive Sentiment: Analyst upgrades/push on valuation: RBC reiterated/raised its price target to $250 (and other firms have set high targets), which supports upside expectations and likely triggered buy interest from momentum and discretionary funds. RBC $250 PT Upgrade
• Positive Sentiment: Fundamentals back the story: Latest quarterly results showed +91.8% revenue growth and an EPS beat with EPS guidance for the next quarter — providing real earnings/margin evidence behind the AI infrastructure narrative. Recent Earnings Report
• Neutral Sentiment: Momentum and institutional interest: Pattern‑based buy signals and hedge‑fund/quant attention are amplifying intraday moves; these factors increase volume and volatility but are technical rather than new fundamental wins. Hedge Fund / Momentum Coverage
• Negative Sentiment: Insider selling: CEO and directors sold sizeable blocks in recent days (multiple Form 4 filings). Sales were executed under pre‑arranged Rule 10b5‑1 plans, which reduces governance alarm but can still weigh on sentiment, especially for short‑term traders. CEO Form 4

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.